Ocular Pharmacokinetics of AzaSite Xtra—2% Azithromycin Formulated in a DuraSite Delivery System

C. W. Erwin, Paul S. Cheung, Lyle M. Bowman, Kamran Hosseini

Current Eye Research · 2009 · 11 citations · 19 references

Abstract

The PK/PD profile of 2% azithromycin suggests efficacy against common causative bacteria with just one dose per day for three days.

References

19